share_log

Behind the Scenes of Eli Lilly's Latest Options Trends

Behind the Scenes of Eli Lilly's Latest Options Trends

Eli Lilly最新的期權趨勢幕後
Benzinga ·  2024/11/29 09:46

Financial giants have made a conspicuous bearish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 8 unusual trades.

金融巨頭對禮來製藥發起了明顯的看淡舉動。我們對禮來製藥 (紐交所: LLY) 的期權歷史進行分析,發現了8筆飛凡交易。

Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $179,046, and 5 were calls, valued at $247,750.

深入細節,我們發現12%的交易者持看好態度,而75%顯示出看淡傾向。在我們發現的所有交易中,有3筆看跌期權,價值179,046美元,5筆看漲期權,價值247,750美元。

Predicted Price Range

預測價格區間

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $1000.0 for Eli Lilly during the past quarter.

分析這些合約的成交量和未平倉量,似乎大戶們在過去一個季度裏一直關注着禮來製藥的股價區間從400.0美元至1000.0美元。

Volume & Open Interest Trends

成交量和未平倉量趨勢

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $400.0 to $1000.0 in the last 30 days.

在交易期權時,查看成交量和未平倉量是一個有效的舉措。這些數據可以幫助您跟蹤給定行權價格的禮來製藥期權的流動性和興趣。下面,我們可以觀察過去30天內,對所有禮來製藥價格區間從400.0美元至1000.0美元的大宗交易分別進行了看漲和看跌的成交量和未平倉量的發展趨勢。

Eli Lilly Option Activity Analysis: Last 30 Days

Eli Lilly期權活動分析:最近30天

bigjpg

Largest Options Trades Observed:

觀察到的最大期權交易:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
LLY CALL TRADE BEARISH 01/15/27 $101.8 $98.0 $98.0 $1000.00 $98.0K 91 10
LLY PUT TRADE BEARISH 12/06/24 $84.05 $77.35 $84.04 $875.00 $75.6K 15 10
LLY PUT TRADE BEARISH 12/19/25 $71.55 $67.0 $71.55 $750.00 $71.5K 320 10
LLY CALL TRADE NEUTRAL 01/17/25 $400.9 $393.6 $397.0 $400.00 $39.7K 371 1
LLY CALL TRADE BEARISH 11/29/24 $41.05 $36.25 $37.75 $755.00 $37.7K 199 10
標的 看跌/看漲 交易類型 情緒 到期日 賣盤 買盤 價格 執行價格 總交易價格 未平倉合約數量 成交量
禮來 看漲 交易 看淡 01/15/27 $101.8 $98.0 $98.0 $1000.00 $98.0K 91 10
禮來 看跌 交易 看淡 12/06/24 $84.05 $77.35 $84.04 $875.00 $75.6K 15 10
禮來 看跌 交易 看淡 12/19/25 $71.55 $67.0 $71.55 $750.00 $71.5千美元 320 10
禮來 看漲 交易 中立 01/17/25 $400.9 $393.6 $397.0 $400.00 $39.7K 371 1
禮來 看漲 交易 看淡 11/29/24 $41.05 $36.25 $37.75 $755.00 $37.7千美元 199 10

About Eli Lilly

關於Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Lilly是一家專注於神經科學,心臟代謝,癌症和免疫學的藥物公司。Lilly的主要產品包括用於治療癌症的Verzenio;用於心臟代謝的Mounjaro,Zepbound,Jardiance,Trulicity,Humalog和Humulin;以及用於免疫學的Taltz和Olumiant。

Current Position of Eli Lilly

Eli Lilly的當前位置

  • With a volume of 8,286, the price of LLY is up 0.07% at $788.76.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 67 days.
  • 擁有8,286的成交量,LLY的價格上漲0.07%,報788.76美元。
  • RSI指標暗示該標的股票目前處於超買和超賣的中立區間。
  • 下一次盈利預計將在67天后發佈。

What The Experts Say On Eli Lilly

關於Eli Lilly,專家們的看法是什麼?

A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1022.5.

過去30天裏,共有4位專業分析師對這支股票發表了看法,並設定了$1022.5的平均目標價。

Unusual Options Activity Detected: Smart Money on the Move

檢測到期權異動:智慧資金在行動。

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Eli Lilly, targeting a price of $975. * An analyst from B of A Securities persists with their Buy rating on Eli Lilly, maintaining a target price of $1100. * An analyst from Wolfe Research has revised its rating downward to Outperform, adjusting the price target to $1000. * An analyst from Deutsche Bank has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1015.

Benzinga Edge的飛凡期權板塊會提前發現潛在的市場變動。看看大資金在你喜愛的股票上的持倉。點擊這裏查看。* 巴克萊銀行的一位分析師繼續持有對Eli Lilly的超配評級,目標價爲$975。* B of A證券的一位分析師堅持對Eli Lilly的買入評級,維持目標價爲$1100。* Wolfe Research的一位分析師將評級下調爲跑贏大盤,並將價格目標調整爲$1000。* 德意志銀行的一位分析師決定繼續維持對Eli Lilly的買入評級,目標價目前爲$1015。

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

期權與僅交易股票相比是一種更具風險的資產,但它們具有更高的利潤潛力。認真的期權交易者通過每日學習,進出交易,跟隨多個指標並密切關注市場來管理這種風險。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論